Page last updated: 2024-08-26

n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and Glioma

n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine has been researched along with Glioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa, T; Herz, A1

Other Studies

1 other study(ies) available for n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and Glioma

ArticleYear
Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.
    Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:19

    Topics: Animals; Benzomorphans; Cell Line; Cell Membrane; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ethylmaleimide; Glioma; GTP Phosphohydrolases; GTP-Binding Proteins; Kinetics; Narcotic Antagonists; Neuroblastoma; Pertussis Toxin; Receptors, Opioid; Receptors, Opioid, delta; Virulence Factors, Bordetella

1989